22 May 2013
Keywords: astellas/neurosearch, initiate, ph, ib, trial, acr16, danish
Article | 16 April 2007
Danish drugmaker NeuroSearch's development and license partner Astellas Pharma has enrolled and dosed the first patients in a clinical
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 April 2007
19 March 2007
12 March 2007
© 2013 thepharmaletter.com